{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:06:20Z","timestamp":1785240380900,"version":"3.55.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clml.2026.04.024","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:32:56Z","timestamp":1778761976000},"page":"e953-e968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SOHO State of the Art Updates and Next Questions | Monoclonal Gammopathy of Clinical Significance: A Multisystem Disorder Requiring a Multidisciplinary Approach"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-3254","authenticated-orcid":false,"given":"Meletios Athanasios","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Theodorakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.clml.2026.04.024_bib0001","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra2412716","article-title":"Monoclonal gammopathy of undetermined significance","volume":"393","author":"Rajkumar","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0002","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.clml.2026.04.024_bib0003","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.clml.2026.04.024_bib0004","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/hematology.2024000573","article-title":"Renal manifestations of MGUS","volume":"2024","author":"Bridoux","year":"2024","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.kint.2025.04.007","article-title":"Renal Pathology Society\/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy\u2013associated kidney lesions","volume":"108","author":"Nasr","year":"2025","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0007","first-page":"2721","article-title":"Non-myeloma light chain cast nephropathy: a multicenter retrospective study on clinicopathological characteristics","volume":"109","author":"Martins","year":"2024","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0008","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.2017.124","article-title":"Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis","volume":"31","author":"Gibier","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0009","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.kint.2025.07.039","article-title":"Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing","volume":"108","author":"Javaugue","year":"2025","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2020.02.025","article-title":"DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients","volume":"98","author":"Said","year":"2020","journal-title":"Kidney Int"},{"issue":"24","key":"10.1016\/j.clml.2026.04.024_bib0011","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic light chain amyloidosis","volume":"390","author":"Sanchorawala","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.ajkd.2021.12.014","article-title":"Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a national French case series","volume":"80","author":"Martins","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0013","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1681\/ASN.2020010054","article-title":"Rate and predictors of finding monoclonal gammopathy of renal significance (MGRS) lesions on kidney biopsy in patients with monoclonal gammopathy","volume":"31","author":"Klomjit","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.clml.2026.04.024_bib0014","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1080\/10428194.2020.1797013","article-title":"Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause","volume":"61","author":"Kastritis","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0015","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3324\/haematol.2019.239632","article-title":"Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls","volume":"105","author":"R\u00f6gnvaldsson","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0016","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminhematol.2025.04.006","article-title":"Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's macroglobulinemia related neuropathy","volume":"62","author":"D'Sa","year":"2025","journal-title":"Semin Hematol"},{"issue":"21","key":"10.1016\/j.clml.2026.04.024_bib0018","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1182\/blood.2020007092","article-title":"CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell\u2013targeted therapies","volume":"136","author":"Le Cann","year":"2020","journal-title":"Blood"},{"issue":"Pt 10","key":"10.1016\/j.clml.2026.04.024_bib0019","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/hematology.2020000122","article-title":"Monoclonal gammopathies of clinical significance","volume":"2020","author":"Dispenzieri","year":"2020","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0021","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1212\/WNL.0000000000007777","article-title":"Sporadic late-onset nemaline myopathy","volume":"93","author":"Naddaf","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0022","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","article-title":"Monoclonal gammopathies and associated skin disorders","volume":"40","author":"Daoud","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.clml.2026.04.024_bib0023","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMra2400092","article-title":"Cryoglobulinemia \u2014 one name for two diseases","volume":"391","author":"Cacoub","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clml.2026.04.024_bib0024","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/hematology.2024000572","article-title":"MGCS: where do we stand today?","volume":"2024","author":"Iberri","year":"2024","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","article-title":"Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients","volume":"69","author":"Rongioletti","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0027","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJMcpc1409840","article-title":"Case records of the Massachusetts General Hospital. Case 8-2015. A 68-year-old man with multiple myeloma, skin tightness, arthralgias, and edema","volume":"372","author":"Wigley","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41408-022-00661-1","article-title":"Cutaneous manifestations of monoclonal gammopathy","volume":"12","author":"Claveau","year":"2022","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0029","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamadermatol.2019.4221","article-title":"A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria","volume":"156","author":"Nelson","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0031","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2015.07.031","article-title":"The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: association with IgA isotype and inflammatory profile","volume":"73","author":"Szalat","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0032","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0033","first-page":"1081","article-title":"Sweet\u2019s syndrome: diagnostic criteria revisited","volume":"15","author":"Nofal","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0034","article-title":"Generalized acquired cutis laxa associated with monoclonal gammopathy of dermatological significance","volume":"2020","author":"Shalhout","year":"2020","journal-title":"Case Rep Dermatol Med"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2026.04.024_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982875","article-title":"Ocular signs and ocular comorbidities in monoclonal gammopathy: analysis of 80 subjects","volume":"2021","author":"Korm\u00e1nyos","year":"2021","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ICO.0b013e31821ddd0c","article-title":"Chameleon-like appearance of immunotactoid keratopathy","volume":"31","author":"Lisch","year":"2012","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.clml.2026.04.024_bib0038","doi-asserted-by":"crossref","first-page":"e987","DOI":"10.1111\/aos.14123","article-title":"Paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS): clinical findings in twelve patients including recurrence after keratoplasty","volume":"97","author":"Skalicka","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0039","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2014.04.007","article-title":"Paraproteinemic maculopathy","volume":"121","author":"Mansour","year":"2014","journal-title":"Ophthalmology"},{"issue":"24","key":"10.1016\/j.clml.2026.04.024_bib0040","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","article-title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study","volume":"115","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020480","article-title":"Monoclonal gammopathy of thrombotic significance","volume":"15","author":"Gkalea","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0042","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/rth2.12333","article-title":"Increased risk of thrombotic events in cold agglutinin disease: a 10-year retrospective analysis","volume":"4","author":"Broome","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0043","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bjh.13183","article-title":"New perspectives on the thrombotic complications of haemolysis","volume":"168","author":"L'Acqua","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0044","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1055\/a-1366-9379","article-title":"Antiphospholipid syndrome with monoclonal gammopathy-a mechanism for recurrent thrombosis?","volume":"121","author":"Doyle","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like monoclonal gammopathy of thrombotic significance","volume":"392","author":"Wang","year":"2025","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.clml.2026.04.024_bib0046","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood.2022018797","article-title":"Monoclonal gammopathy of thrombotic\/thrombocytopenic significance","volume":"141","author":"Kanack","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2025.100093","article-title":"M protein and the evolving spectrum of platelet-activating anti-PF4 disorders and MGTS and their linkage","volume":"2","author":"Mir","year":"2025","journal-title":"Blood Vessel Thromb Hemost"},{"key":"10.1016\/j.clml.2026.04.024_bib0048","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2024-207999","article-title":"Platelet-activating anti-PF4 antibodies in MGUS patients with thrombosis","volume":"144","author":"Pabmanabhan","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0049","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00277-016-2650-x","article-title":"Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias","volume":"95","author":"Dicke","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3324\/haematol.2019.242370","article-title":"Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody","volume":"106","author":"Schell","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0051","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcla.21658","article-title":"The effect of paraprotein on platelet aggregation","volume":"28","author":"Djunic","year":"2014","journal-title":"J Clin Lab Anal"},{"issue":"12","key":"10.1016\/j.clml.2026.04.024_bib0052","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/ajh.27081","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"98","author":"Dispenzieri","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0053","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/leu.2016.168","article-title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0054","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.2021014393","article-title":"TEMPI syndrome associated with IgM monoclonal gammopathy","volume":"139","author":"Kubik","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/10428194.2024.2323084","article-title":"A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathy","volume":"65","author":"Asimakopoulou","year":"2024","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.clml.2026.04.024_bib0056","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1007\/s00277-024-05893-8","article-title":"TEMPI syndrome: difficult to diagnose, \u201ceasy\u201d to treat?","volume":"103","author":"Fotiou","year":"2024","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0057","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaci.2016.10.042","article-title":"Idiopathic systemic capillary leak syndrome (Clarkson disease)","volume":"140","author":"Druey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.clml.2026.04.024_bib0058","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am J Hematol"},{"issue":"15","key":"10.1016\/j.clml.2026.04.024_bib0059","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood.2019004216","article-title":"The TEMPI syndrome","volume":"135","author":"Sykes","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13196","article-title":"Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases","volume":"168","author":"Harel","year":"2015","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0061","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0062","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.kint.2024.02.027","article-title":"Monoclonal immunoglobulin crystalline nephropathies","volume":"106","author":"Nasr","year":"2024","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.clml.2026.04.024_bib0063","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ophtha.2015.05.029","article-title":"Paraproteinemic keratopathy: the expanding diversity of clinical and pathologic manifestations","volume":"122","author":"Milman","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0064","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0065","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0066","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/hematology.2025000718","article-title":"Diagnosis and management of cold agglutinin disease","volume":"2025","author":"Berentsen","year":"2025","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.clml.2026.04.024_bib0067","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11940-017-0479-9","article-title":"Advances in the treatment of paraproteinemic neuropathy","volume":"19","author":"Nobile-Orazio","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0068","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00005792-199907000-00003","article-title":"Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders","volume":"78","author":"Aractingi","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"33","key":"10.1016\/j.clml.2026.04.024_bib0069","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.clml.2026.04.024_bib0070","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2011-05-356907","article-title":"Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy","volume":"118","author":"Szalat","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0071","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMc2406453","article-title":"Myeloma therapy for monoclonal gammopathy of thrombotic significance","volume":"391","author":"Salmasi","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clml.2026.04.024_bib0072","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0073","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.ajkd.2004.09.029","article-title":"Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2 chains of type IV collagen","volume":"45","author":"Borza","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0074","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and\u2002de novo\u2002membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0075","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.jcjo.2013.07.018","article-title":"Monoclonal gammopathy of undetermined significance maculopathy","volume":"48","author":"Saffra","year":"2013","journal-title":"Canadian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0076","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ejh.12189","article-title":"14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome","volume":"91","author":"Kang","year":"2013","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.clml.2026.04.024_bib0077","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2017-10-810366","article-title":"Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome","volume":"131","author":"Rowczenio","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2026.04.024_bib0078","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/bloodadvances.2020003783","article-title":"Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome","volume":"5","author":"Sun","year":"2021","journal-title":"Blood Advances"},{"key":"10.1016\/j.clml.2026.04.024_bib0079","first-page":"1","article-title":"Remission of recurrent systemic capillary leak syndrome associated with monoclonal gammopathy following anti-myeloma treatment \u2013 a case report and literature review","author":"Gavriatopoulou","year":"2025","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"10.1016\/j.clml.2026.04.024_bib0080","first-page":"1101","article-title":"Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema","volume":"135","author":"Mah\u00e9vas","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0081","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0000000000000477","article-title":"Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance","volume":"30","author":"Uruha","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"20","key":"10.1016\/j.clml.2026.04.024_bib0082","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0083","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective","volume":"36","author":"Bridoux","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0084","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee report","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J"},{"issue":"20","key":"10.1016\/j.clml.2026.04.024_bib0085","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood.2019004197","article-title":"Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome","volume":"135","author":"Bender","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0086","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era","volume":"27","author":"Stokes","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0087","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/leu.2016.195","article-title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients","volume":"31","author":"Vignon","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0088","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0089","first-page":"353","article-title":"Les autoanticorps IgM anti-MAG par Elisa B\u00fchlmann\u202f: apport diagnostique dans 117 neuropathies p\u00e9riph\u00e9riques auto-immunes associ\u00e9es \u00e0 une IgM monoclonale \u00e0 activit\u00e9 anti-SGPG\/SGLPG","volume":"64","author":"Caudie","year":"2006","journal-title":"Ann Clin Biol"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0090","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJMc1205806","article-title":"Complete and partial responses of the TEMPI syndrome to bortezomib","volume":"367","author":"Schroyens","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clml.2026.04.024_bib0091","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2015.298","article-title":"Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation","volume":"29","author":"Kenderian","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0092","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0093","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1080\/10428194.2016.1267349","article-title":"Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens","volume":"58","author":"Ziogas","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"10.1016\/j.clml.2026.04.024_bib0094","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2026.04.024_bib0096","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ajh.24528","article-title":"Outcomes of patients with renal monoclonal immunoglobulin deposition disease","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0097","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bjh.17052","article-title":"Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance","volume":"193","author":"Kastritis","year":"2021","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.clml.2026.04.024_bib0098","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajh.26566","article-title":"Monoclonal gammopathy of renal significance (MGRS): real-world data on outcomes and prognostic factors","volume":"97","author":"Gozzetti","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0099","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","article-title":"Outcomes of patients with POEMS syndrome treated initially with radiation","volume":"122","author":"Humeniuk","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clml.2026.04.024_bib0100","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/s41375-018-0209-7","article-title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","volume":"32","author":"Gavriatopoulou","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.clml.2026.04.024_bib0101","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000381","article-title":"Upfront Daratumumab with lenalidomide and dexamethasone for POEMS syndrome","volume":"4","author":"Gavriatopoulou","year":"2020","journal-title":"Hemasphere"},{"issue":"23","key":"10.1016\/j.clml.2026.04.024_bib0102","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMc1804415","article-title":"Complete responses in the TEMPI syndrome after treatment with daratumumab","volume":"378","author":"Sykes","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0103","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00277-019-03761-4","article-title":"Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone","volume":"98","author":"Liang","year":"2019","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000525056","article-title":"Successful treatment of the TEMPI syndrome with pomalidomide plus dexamethasone followed by autologous stem cell transplantation","volume":"145","author":"Kawamura","year":"2022","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0107","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","article-title":"Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience","volume":"120","author":"D'Souza","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2026.04.024_bib0108","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2015.298","article-title":"Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation","volume":"29","author":"Kenderian","year":"2015","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0109","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archderm.141.10.1277","article-title":"Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation","volume":"141","author":"Lacy","year":"2005","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.clml.2026.04.024_bib0110","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.humpath.2012.10.012","article-title":"Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome","volume":"44","author":"Duquesne","year":"2013","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0111","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061710","article-title":"Venetoclax in relapse\/refractory AL amyloidosis-a multicenter international retrospective real-world study","volume":"15","author":"Lebel","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0112","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/j.clml.2020.03.013","article-title":"Venetoclax in a patient with light chain deposition disease secondary to MGRS that progressed after kidney transplantation","volume":"20","author":"Leung","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10.1016\/j.clml.2026.04.024_bib0113","first-page":"1891","article-title":"Teclistamab therapy for refractory type 1 cryoglobulinemia","volume":"110","author":"Battaglini","year":"2025","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2023.03.005","article-title":"Report of consensus panel 1 from the 11(th) International Workshop on Waldenstrom's macroglobulinemia on management of symptomatic, treatment-na\u00efve patients","volume":"60","author":"Buske","year":"2023","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.seminhematol.2023.03.002","article-title":"Report of Consensus Panel 6 from the 11 th International Workshop on Waldenstr\u00f6m's macroglobulinemia on management of Waldenstr\u00f6m's macroglobulinemia related amyloidosis","volume":"60","author":"Merlini","year":"2023","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.04.024_bib0116","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2023.03.003","article-title":"Report of consensus panel 2 from the 11th international workshop on Waldenstr\u00f6m's macroglobulinemia on the management of relapsed or refractory WM patients","volume":"60","author":"D'Sa","year":"2023","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0117","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000720","article-title":"The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy","volume":"7","author":"Castellani","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0118","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/acr.23908","article-title":"Clinical and molecular phenotyping in scleromyxedema pretreatment and posttreatment with intravenous immunoglobulin","volume":"72","author":"Mecoli","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.clml.2026.04.024_bib0119","doi-asserted-by":"crossref","first-page":"1219.e1219","DOI":"10.1016\/j.amjmed.2017.05.023","article-title":"Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome","volume":"130","author":"Pineton de Chambrun","year":"2017","journal-title":"Am J Med"},{"issue":"10424","key":"10.1016\/j.clml.2026.04.024_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0121","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","volume":"145","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"10.1016\/j.clml.2026.04.024_bib0122","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215247","article-title":"Monoclonal gammopathies of clinical significance: a critical appraisal","volume":"14","author":"R\u00edos-Tamayo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.clml.2026.04.024_bib0123","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/10428194.2021.2008385","article-title":"Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes","volume":"63","author":"Garderet","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjmed.2014.08.015","article-title":"High-dose intravenous immunoglobulin therapy for systemic capillary leak syndrome (Clarkson disease)","volume":"128","author":"Xie","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2026.04.024_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1045002","article-title":"Monoclonal gammopathies of clinical significance (MGCS): in pursuit of optimal treatment","volume":"13","author":"Oganesyan","year":"2022","journal-title":"Front Immunol"},{"issue":"36","key":"10.1016\/j.clml.2026.04.024_bib0126","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.04.024_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2020.1868810","article-title":"Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis","volume":"28","author":"Palladini","year":"2021","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.clml.2026.04.024_bib0128","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000908","article-title":"Prevalence of MGCS among patients with monoclonal gammopathies","volume":"7","author":"Theodorakakou","year":"2023","journal-title":"Hemasphere"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:55:38Z","timestamp":1785239738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2152265026001382"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.04.024","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOHO State of the Art Updates and Next Questions | Monoclonal Gammopathy of Clinical Significance: A Multisystem Disorder Requiring a Multidisciplinary Approach","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}